The binding of physostigmine to human serum albumin

J Pharm Pharmacol. 1990 Nov;42(11):804-5. doi: 10.1111/j.2042-7158.1990.tb07027.x.

Abstract

The binding of [3H]physostigmine to crystallized human serum albumin (HSA) has been investigated using equilibrium dialysis. The percentage bound to 1% (w/v) HSA decreased from 18 to 4% as the total concentration of physostigmine increased from 3.3 nM to 2.7 microM (0.9 to 750 ng mL-1). A single class of specific binding sites with a large affinity constant, K = 8 x 10(7) L mol-1, was identified. The concentration of binding sites was approximately 3 nM. The Michaelis constants for human serum cholinesterase and albumin were the same; an explanation for these results is that the drug is binding to a trace cholinesterase, in the albumin.

MeSH terms

  • Binding Sites
  • Cholinesterases / blood
  • Cholinesterases / metabolism
  • Chromatography, High Pressure Liquid
  • Humans
  • Kinetics
  • Physostigmine / blood
  • Physostigmine / metabolism*
  • Serum Albumin / metabolism*

Substances

  • Serum Albumin
  • Physostigmine
  • Cholinesterases